文献速递胃肠外科围术期管理与 ERAS

结直肠癌减孔腹腔镜手术标本取出:自然腔道与常规小切口倾向评分匹配对比研究

Natural orifice versus conventional mini-laparotomy for specimen extraction after reduced-port laparoscopic surgery for colorectal cancer: propensity score-matched comparative study.
PubMed 文献 · Surg Endosc · 2021-02-02

本研究回顾性分析2013-2019年单中心119例AJCC I-III期乙状结肠或上段直肠癌(肿瘤直径≤5cm)行减孔腹腔镜前切除术患者,倾向评分1:1匹配后各52例比较自然腔道标本取出(RPLS-NOSE)与常规小切口标本取出(RPLS-CSE)。RPLS-NOSE手术时间更长(223.9 vs 188.7 min,p=0.003),但镇痛药用量更少(吗啡33.9 vs 43.4 mg,p=0.011)、住院时间更短(4.2 vs 5.1天,p=0.001),两组并发症和3年无病生存率(90.9% vs 90.5%,p=0.610)无显著差异。

要点

  • RPLS-NOSE可避免腹壁标本取出切口,增强减孔腹腔镜微创优势。
  • 肿瘤直径≤5cm患者中,RPLS-NOSE的3年肿瘤学安全性与RPLS-CSE相当。

核心结论

  • 对于肿瘤直径≤5cm的结直肠癌患者,RPLS-NOSE通过避免腹壁标本取出切口增强RPLS微创优势,手术和肿瘤学安全性与RPLS-CSE相当。

研究设计与样本

  • 单中心回顾性分析2013-2019年前瞻性收集的119例AJCC I-III期乙状结肠或上段直肠癌(肿瘤直径≤5cm)行RPLS根治性前切除术患者记录。
  • 排除未行肠道吻合患者,按肿瘤直径、AJCC分期、ASA评分和肿瘤位置进行1:1倾向评分匹配,最终104例匹配(52例RPLS-NOSE,52例RPLS-CSE)。

主要发现

  • RPLS-NOSE组手术时间显著长于RPLS-CSE组(223.9 vs 188.7 min,p=0.003)。
  • RPLS-NOSE组镇痛药用量(吗啡33.9 vs 43.4 mg,p=0.011)和住院时间(4.2 vs 5.1天,p=0.001)显著低于RPLS-CSE组。
  • 两组并发症率和伤口相关并发症率无统计学显著差异;中位随访34.3个月,RPLS-NOSE组无局部复发。
  • 两组3年无病生存率无统计学显著差异(90.9% vs 90.5%,p=0.610)。

临床怎么用

  • 对于肿瘤直径≤5cm的乙状结肠或上段直肠癌行RPLS前切除术患者,可考虑采用自然腔道标本取出以避免腹壁辅助切口。
  • 采用RPLS-NOSE时需考虑手术时间可能延长,但可减少术后镇痛药需求和缩短住院时间。

局限性

  • 单中心回顾性研究,样本量有限(匹配后104例),结论需多中心前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although reduced port laparoscopic surgery (RPLS), defined as laparoscopic surgery performed with the minimum possible number of ports and/or small-sized ports, is less invasive than conventional laparoscopic surgery by reducing the number of surgical wounds, an extension of the incision is still needed for specimen extraction, which can undermine the merits of RPLS. OBJECTIVE: To determine the impact of natural orifice specimen extraction (NOSE) in patients undergoing RPLS for colorectal cancer. The endpoints were perioperative outcome and oncologic safety at 3 years. SETTING: Single-center experience (2013-2019). PATIENTS: We retrospectively analyzed our prospectively collected patient records (American Joint Committee on Cancer (AJCC) stage I-III sigmoid or upper rectal cancer (tumor diameter ≤ 5 cm) who underwent curative anterior resection via RPLS. We excluded patients who did not undergo intestinal anastomosis. INTERVENTIONS: Perioperative and oncologic outcomes were compared between patients undergoing natural orifice (RPLS-NOSE) or conventional (mini-laparotomy) specimen extraction (RPLS-CSE). Patients were matched by propensity scores 1:1 for tumor diameter, AJCC stage, American Society of Anesthesiologists score and tumor location. RESULTS: Of 119 eligible patients, 104 were matched (52 RPLS-NOSE; 52 RPLS-CSE) by propensity scores. Compared with RPLS-CSE, RPLS-NOSE was associated with longer operative time (223.9 vs. 188.7 min; p = 0.003), decreased use of analgesics (morphine dose 33.9 vs. 43.4 mg; p = 0.011) and duration of hospital stay (4.2 vs. 5.1 days; p = 0.001). No statistically significant difference was found in morbidity or wound-related complication rates between the two groups. After a median follow-up of 34.3 months, no local recurrence was observed in RPLS-NOSE. The 3-year disease-free survival did not differ statistically significantly between groups (90.9 vs. 90.5%; p = 0.610). CONCLUSION: NOSE enhances the advantages of RPLS by avoiding the need for abdominal wall specimen extraction in patients with tumor diameter ≤ 5 cm. Surgical and oncologic safety are comparable to RPLS with CSE.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Chang SC, Lee TH, Chen YC, et al. Natural orifice versus conventional mini-laparotomy for specimen extraction after reduced-port laparoscopic surgery for colorectal cancer: propensity score-matched comparative study. Surg Endosc. 2021. PMID: 33532930. doi:10.1007/s00464-020-08250-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。